Correlative Studies in Conjunction with A Phase 2 Trial of Alemtuzumab-Ofatumumab Combination in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2011
At a glance
- Drugs Alemtuzumab; Ofatumumab
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 01 Sep 2011 New trial record